Chimeric antigen receptors for stem cell based immunotherapy

Journal of Experimental Therapeutics and Oncology

Volumn 8, Issue 1, 2009, Pages 53-63

  Badowski, Michael S ^a   Zhang, Tong ^b   Tsang, Tom C ^a   Harris, David T ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Cancer; Chimeric antigen receptor; HER2; Immunotherapy; Stem cell

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LYMPHOCYTE ANTIGEN RECEPTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; CELL LINE, TUMOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTHERAPY; INTERLEUKIN-2; MICE; NEOPLASMS; RECEPTOR, ERBB-2; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS;

EID: 70349189946     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lee, YT, Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases. Surgery, Gynocology & Obstetrics, 1977. 144(3): p. 435-450.
2. Villa, A, Cairo, G, Pozzi, M, Schiaffonati, L, Bardella, L, Lucchini, R, Delia, D, Besana, C, Biunno, I, and Vezzoni, P, Lack of TdT and immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease. Int J Bio Markers, 1987. 2(2): p. 65-70.
3. De Baetselier, P, Katzav, S, Gorelik, E, Feldman, M, and Segal, S, Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties. Nature, 1980. 288(5787): p. 179-181. (Pubitemid 11212608)
4. Gopas, J, Rager-Zisman, B, Bar-Eli, M, Hämmerling, G, and S, S, The relationship between MHC antigen expression and metastasis. Adv Cancer Res, 1989. 53: p. 89-115.
5. Hammerling, G, Klar, D, Pulm, W, Momburg, F, and Moldenhauer, G, The influence of major histocompatibility complex class I antigens on tumor growth and metastasis. Biochim Biophys Acta, 1987. 907(3): p. 245-259. (Pubitemid 18005338)
6. Hamaoka, T, Haba, S, Takatsu, K, and Kitagawa, M, Selective inhibition of T lymphocyte repopulation of lymphoid organs as a mechanism of immunosuppression in tumor-bearing mice. Int J Cancer, 1976. 18(5): p. 612-621.
7. Ablin, RJ, Bartkus, JM, Gonder, MJ, and Polgar, J. Factors contributing to Suppression of Tumour-Host Responsiveness, p. 279. Proceeedings of the 3rd International Converence on Human Tumour Markers - Biology and Clinical Applications. 1986. Lacco Ameno d'Ischia (Naples): Walter de Gruyter, 1987.
8. Mitchison, NA, Studies on the immunological response to foreign tumor transplants in the mouse. J Exp Med, 1955. 102(2): p. 157-177.
9. Barr, IG, MacDonald, HR, Buchegger, F, and von Fliedner, V, Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies. Int J Cancer, 1987. 40(3): p. 423-429. (Pubitemid 17156140)
10. Eshhar, Z, The T-Body Approach: Redirecting T Cells with Antibody Specificity, 329-342 in Therapeutic Antibodies. 2008.
11. Apiranthitou-Drogari, M, Paganin, C, Bernasconi, S, Losa, G, Maneo, A, Colombo, N, Mantovani, A, and Allavena, P, In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma. Cancer Immunol Immunother, 1992. 35(4).
12. Baxevanis, CN, Dedoussis, GV, Papadopoulos, NG, Missitzis, I, Stathopoulos, GP, and Papamichail, M, Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer, 1994. 74(4): p. 1275-1282. (Pubitemid 24301780)
13. Mukherji, B, Chakraborty, NG, and Sivanandham, M, T-cell clones that react against autologous human tumors. Immunol Rev, 1990(116): p. 33-62. (Pubitemid 20283615)
14. Yang, S, Darrow, TL, and Seigler, HF, Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Research, 1997. 57: p. 1561. (Pubitemid 27175575)
15. Mackensen, A, Wittnebel, S, Veelken, H, Noppen, C, Spagnoli, GC, and Lindermann, A, Induction and large-scale expansion of CD8+ tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells. European Cytokine Network, 1999. 10(3): p. 329-336. (Pubitemid 29415385)
16. Park, JR, Digiusto, DL, Slovak, M, Wright, C, Naranjo, A, Wagner, J, Meechoovet, HB, Bautista, C, Chang, WC, Ostberg, JR, and Jensen, MC, Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma. Mol Ther, 2007. 15(4): p. 825-833. (Pubitemid 46432004)
17. Barrette, S, Douglas, JL, Seidel, NE, and Bodine, DM, Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to Moloney murine leukemia virus-based vectors. Blood, 2000. 96(10): p. 3385-3391. (Pubitemid 30836316)
18. Wilkie, S, Picco, G, Foster, J, Davies, DM, Julien, S, Cooper, L, Arif, S, Mather, SJ, Taylor-Papadimitriou, J, Burchell, JM, and Maher, J, Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor. J Immunol, 2008. 180(7): p. 4901-4909.
19. Sharkis, SJ, Collector, MI, Barber, JP, Vala, MS, and Jones, RJ, Phenotypic and functional characterization of the hematopoietic stem cell. Stem Cells, 1997. 15 Suppl. 1: p. 41-44.
20. Krause, DS, Theise, ND, Collector, MI, Henegariu, O, Hwang, S, Gardner, R, Neutzel, S, and Sharkis, SJ, Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell. Cell, 2001. 105(3): p. 369-377. (Pubitemid 32455343)
21. Saule, S, Roussel, M, Lagrou, C, and Stehelin, D, Characterization of the oncogene (erb) of avian erythroblastosis virus and its cellular progenitor. J. Virol., 1981. 38(2): p. 409-419. (Pubitemid 11098333)
22. Caneveri, S, Mezzanzanica, D, Ménard, S, Ferrini, S, Moretta, L, and Colnaghi, MI, Possible targets on carcinoma for bMAb retargeting of lymphocyte or drug cytotoxicity. Int J Cancer Suppl, 1992(7): p. 42-44.
23. Kaumaya, PTP, HER-2/neu Cancer Vaccines: Present Status and Future Prospects. International Journal of Peptide Research and Therapeutics, 2006. 12(1): p. 65-77.
24. Fendly, BM, Winget, M, Hudziak, RM, Lipari, MT, Napier, MA, and Ullrich, A, Characterization of Murine Monoclonal Antibodies Reactive to Either the Human Epidermal Growth Factor Receptor or HER2/neu Gene Product. Cancer Res, 1990. 50(5): p. 1550-1558. (Pubitemid 20090470)
25. Ercolini, AM, Machiels, J-PH, Chen, YC, Slansky, JE, Giedlen, M, Reilly, RT, and Jaffee, EM, Identification and Characterization of the Immunodominant Rat HER-2/ neu MHC Class I Epitope Presented by Spontaneous Mammary Tumors from HER-2/ neu-Transgenic Mice. J Immunol, 2003. 170(8): p. 4273-4280. (Pubitemid 36428195)
26. Zhang, T, He, X, Tsang, TC, and Harris, DT, Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther, 2004. 11(7): p. 487-496. (Pubitemid 38902675)
27. Lefranc, MP, Giudicelli, V, Ginestoux, C, Bodmer, J, Muller, W, Bontrop, R, Lemaitre, M, Malik, A, Barbie, V, and Chaume, D, IMGT, the international ImMunoGeneTics database. Nucl. Acids Res., 1999. 27(1): p. 209-212.
28. Sambrook, J and Russell, DW, Molecular Cloning: A Laboratory Manual. 3 ed. Vol.2. 2001, Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
29. Warrens, AN, Jones, MD, and Lechler, RI, Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene, 1997. 186(1): p. 29-35.
30. Miyoshi, H, Smith, KA, Mosier, DE, Verma, IM, and Torbett, BE, Transduction of Human CD34+ Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors. Science, 1999. 283(5402): p. 682-686. (Pubitemid 29075006)
31. Burns, JC, Friedmann, T, Driever, W, Burrascano, M, and Yee, JK, Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 1993. 90(17): p. 8033-8037. (Pubitemid 23260849)
32. Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D, and Naldini, L, A Third-Generation Lentivirus Vector with a Conditional Packaging System. J. Virol., 1998. 72(11): p. 8463-8471. (Pubitemid 28471781)
33. Cheng, L, Fu, J, Tsukamoto, A, and Hawley, RG, Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnology, 1996. 14(5): p. 606-609. (Pubitemid 26135124)
34. White, SM, Renda, M, Nam, N-Y, Klimatcheva, E, Zhu, Y, Fisk, J, Halterman, M, Rimel, BJ, Federoff, H, Pandya, S, Rosenblatt, JD, and Planelles, V, Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements. J. Virol., 1999. 73(4): p. 2832-2840. (Pubitemid 29135670)
35. Sastry, L, Johnson, T, Hobson, MJ, Smucker, B, and Cornetta, K, Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Therapy, 2002. 9(17): p. 1155. (Pubitemid 34993938)
36. Ailles, L, Schmidt, M, Santoni de Sio, FR, Glimm, H, Cavalieri, S, Bruno, S, Piacibello, W, Von Kalle, C, and Naldini, L, Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, longterm NOD/SCID repopulating hematopoietic cells. Mol Ther, 2002. 6(5): p. 615-626. (Pubitemid 35363694)
37. Golde, WT, Gollobin, P, and Rodriguez, LL, A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Animal, 2005. 34(9): p. 39-43. (Pubitemid 44662092)
38. Hudziak, RM, Lewis, GD, Winget, M, Fendly, BM, Shepard, HM, and Ullrich, A, p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol., 1989. 9(3): p. 1165-1172 (Pubitemid 19071685)
39. Sarup, JC, Johnson, RM, King, KL, Fendly, BM, Lipari, MT, Napier, MA, Ullrich, A, and Shepard, HM, Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. Growth Regul, 1991 Jun. 1(2): p. 72-82.
40. Lewis, GD, Figari, I, Fendly, B, Lee Wong, W, Carter, P, Gorman, C, and Shepard, HM, Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies. Cancer Immunology, Immunotherapy, 1993. 37(4): p. 255-263. (Pubitemid 23300507)
41. Kern, JA, Torney, L, Weiner, D, Gazdar, A, Shepard, HM, and Fendly, B, Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. Am J Respir Cell Mol Biol, 1993 Oct. 9(4): p. 488-1454
42. Huston, JS, Levinson, D, Mudgett-Hunter, M, Tai, MS, Novotnà 1/2, J, Margolies, MN, Ridge, RJ, Bruccoleri, RE, Haber, E, and Crea, R, Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 1988. 85(16): p. 5879-5883.
43. Bird, RE, Hardman, KD, Jacobson, JW, Johnson, S, Kaufman, BM, Lee, SM, Lee, T, Pope, SH, Riordan, GS, and Whitlow, M, Single-chain antigen-binding proteins. Science, 1988. 242(4877): p. 423-426.
44. Straus, DB and Weiss, A, Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell, 1992. 70(4): p. 585-593.
45. Goldsmith, MA and Weiss, A, Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proceedings of the National Academy of Sciences of the United States of America, 1987. 84(19): p. 6879-6883.
46. Cancer Statistics Review 1975-2005, in SEER. 2008, National Cancer Institute, Centers for Disease Control and Prevention. p. 78.
47. Ablin, RJ, Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology, 1975. 31(3-4): p. 177-202.
48. Hanahan, D and Weinberg, RA, The Hallmarks of Cancer. Cell, 2000. 100(1): p. 57-70.
49. Tal, M, Wetzler, M, Josefberg, Z, Deutch, A, Gutman, M, Assaf, D, Kris, R, Shiloh, Y, Givol, D, and Schlessinger, J, Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res, 1988 Mar 15. 48(6): p. 1517-1520. (Pubitemid 18091199)
50. Kern, J, Schwartz, D, Nordberg, J, Weiner, D, Greene, M, Torney, L, and Robinson, R, p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res, 1990 Aug 15. 50(16): p. 5184-5187. (Pubitemid 20257954)
51. Casrouge, A, Beaudoing, E, Dalle, S, Pannetier, C, Kanellopoulos, J, and Kourilsky, P, Size Estimate of the {alpha} {beta} TCR Repertoire of Naive Mouse Splenocytes. J Immunol, 2000. 164(11): p. 5782-5787. (Pubitemid 30389821)
52. Doherty, PC, Riberdy, JM, and Belz, GT, Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses. Philos Trans R Soc Lond B Biol Sci, 2000. 355(1400): p. 1093-1101.